NCT07166445View on ClinicalTrials.gov

Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2027

Conditions
Carcinoma, Renal CellDiagnostic ImagingPathologyDeep Learning
Interventions
OTHER

None intervention

this study is retrospective based on the CT images, which dose include any intervention.

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing,, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER